Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-21T09:21:22.093Z Has data issue: false hasContentIssue false
  • English
  • Français

Athletic participation in the young patient with an implantable cardioverter-defibrillator

Published online by Cambridge University Press:  13 January 2017

Rachel Lampert  and
Ian Law
Rachel Lampert*
Affiliation:
Department of Internal Medicine, Yale University, New Haven, CT, United States of America
Ian Law
Affiliation:
Pediatric Electrophysiology, University of Iowa School of Medicine, Iowa City, IA, United States of America
*
Correspondence to: R. Lampert, MD, 789 Howard Avenue #3, New Haven, CT, United States of America. Tel: 203 737 4068; Fax: 203 785 6506; E-mail: Rachel.lampert@yale.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

The decision of whether to allow a young patient with an implantable cardioverter-defibrillator to continue to participate in sports is complex and multi-factorial. The positive physical and psychosocial impact of sports participation must be weighed against the potential adverse events associated with implantable cardioverter-defibrillators. Arrhythmias appear to be more prevalent in athletes and occur more frequently during physical activity or competition/practice, but there is growing evidence that device therapy is effective in athletes across a wide range of competitive sports. Failure of a device to convert a life-threatening arrhythmia, major injury from a shock, and increased lead failure have thus far not been reported in the prospective Implantable Cardioverter-Defibrillator Sports Registry, but follow-up remains relatively short. Thoughtful consideration of disease state, arrhythmia risk, and the potential dangers of device therapy during the desired sports is imperative before allowing participation. Frank discussion with children and families regarding the possibility of shocks during sports, as well as at other times, is imperative. Ongoing and future studies will help guide these decisions.

Keywords

Implantable cardioverter-defibrillatorathletic participationpaediatricsprimary preventionsecondary prevention
Type
Original Articles
Information
Cardiology in the Young , Volume 27 , Supplement S1: Sudden Cardiac Arrest in the Young: A Contemporary Perspective , January 2017 , pp. S132 - S137
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Lampert, R, Cannom, D. Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision. Heart Rhythm 2008; 5: 861–863.CrossRefGoogle ScholarPubMed
2. Maron, BJ, Zipes, D. It is not prudent to allow all athletes with implantable cardioverter-defibrillators to participate in all sports. Heart Rhythm 2008; 5: 864–866.Google Scholar
3. Priori, SG, Wilde, AA, Horie, M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013; 10: 1932–1963.Google Scholar
4. Ackerman, MJ, Priori, SG, Willems, S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8: 1308–1339.Google Scholar
5. Coris, EE, Sahebzamani, F, Curtis, A, et al. Preparticipation cardiovascular screening among National Collegiate Athletic Association Division I institutions. Br J Sports Med 2013; 47: 182–184.Google Scholar
6. Maron, BJ, Zipes, DP. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2005; 45: 1313–1375.CrossRefGoogle Scholar
7. McAllister, DR, Motamedi, AR, Hame, SL, Shapiro, MS, Dorey, FJ. Quality of life assessment in elite collegiate athletes. Am J Sports Med 2001; 29: 806–810.CrossRefGoogle ScholarPubMed
8. Czosek, RJ, Bonney, WJ, Cassedy, A, et al. Impact of cardiac devices on the quality of life in pediatric patients. Circ Arrhythm Electrophysiol 2012; 5: 1064–1072.Google Scholar
9. Rahman, B, Macciocca, I, Sahhar, M, Kamberi, S, Connell, V, Duncan, RE. Adolescents with implantable cardioverter defibrillators: a patient and parent perspective. Pacing Clin Electrophysiol 2012; 35: 62–72.CrossRefGoogle ScholarPubMed
10. Lampert, R, Olshansky, B, Heidbuchel, H, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation 2013; 127: 2021–2030.CrossRefGoogle ScholarPubMed
11. Antzelevitch, C, Brugada, P, Brugada, J, et al. Brugada syndrome: a decade of progress. Circ Res 2002; 91: 1114–1118.CrossRefGoogle ScholarPubMed
12. van den Berg, MP, Wilde, AA, Viersma, TJW, et al. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 2001; 12: 630–636.Google Scholar
13. Ackerman, MJ, Tester, DJ, Porter, CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc 1999; 74: 1088–1094.Google Scholar
14. Corrado, D, Basso, C, Rizzoli, G, Schiavon, S, Thiene, G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959–1963.CrossRefGoogle ScholarPubMed
15. Kirchhof, P, Fabritz, L, Zwiener, M, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 2006; 114: 1799–1806.CrossRefGoogle ScholarPubMed
16. James, CA, Bhonsale, A, Tichnell, C, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013; 14: 1290–1297.CrossRefGoogle Scholar
17. Rojas, A, Calkins, H. Present understanding of the relationship between exercise and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Trends Cardiovasc Med 2015; 25: 181–188.CrossRefGoogle ScholarPubMed
18. Berul, CI, Van Hare, GF, Kertesz, NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51: 1685–1691.CrossRefGoogle ScholarPubMed
19. Von Bergen, NH, Atkins, DL, Dick, M 2nd, et al. Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease. Pediatr Cardiol 2011; 32: 399–405.CrossRefGoogle Scholar
20. Lampert, R, Cannom, D, Olshansky, B. Safety of sports participation in patients with implantable cardioverter-defibrillators: a survey of Heart Rhythm Society members. J Cardiovasc Electrophysiol 2006; 17: 11–15.CrossRefGoogle ScholarPubMed
21. Providência, R, Kramer, DB, Pimenta, D, et al. Transvenous implantable cardioverter-defibrillator (ICD) lead performance: a meta-analysis of observational studies. J Am Heart Assoc 2015; 4: 1–14.Google Scholar
22. Atallah, J, Erickson, CC, Cecchin, F, et al. Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study. Circulation 2013; 127: 2393–2402.CrossRefGoogle Scholar
23. Schron, EB, Exner, DV, Yao, Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators. Circulation 2002; 105: 589–594.CrossRefGoogle ScholarPubMed
24. Eccles, JS, Barber, BL, Stone, M, Hunt, J. Extracurricular activities and adolescent development. J Soc Issues 2003; 59: 865–889.Google Scholar
25. Marsh, HW, Kleitman, S. Extracurricular school activities: the good, the bad, and the nonlinear. Harvard Educ Rev 2002; 72: 464–514.CrossRefGoogle Scholar